Relations among glycemic control, circulating endothelial cells, nitric oxide, and flow mediated dilation in patients with type 2 diabetes mellitus

Experimental and Clinical Endocrinology and Diabetes

Volumn 120, Issue 8, 2012, Pages 460-465

  Kotb, N A ^a   Gaber, R ^a   Salah, W ^a   Elhendy, A ^b  

^a TANTA UNIVERSITY   (Egypt)

^b MARSHFIELD CLINIC   (United States)

Author keywords

circulating endothelial cells; diabetes mellitus; endothelial function; nitric oxide

Indexed keywords

ANTIDIABETIC AGENT; HEMOGLOBIN A1C; INSULIN; NITRIC OXIDE;

ADULT; ARTICLE; BRACHIAL ARTERY; CELL COUNT; CELL FUNCTION; CIRCULATING ENDOTHELIAL CELL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE CONTROL; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; GLYCEMIC CONTROL; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD146; BIOLOGICAL MARKERS; BLOOD CELL COUNT; BRACHIAL ARTERY; CELL-DERIVED MICROPARTICLES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; FLOW CYTOMETRY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; NITRIC OXIDE; VASODILATION;

EID: 84866356808     PISSN: 09477349     EISSN: 14393646     Source Type: Journal    
DOI: 10.1055/s-0032-1306349     Document Type: Article

References (39)

1. Celermajer D S. Endothelial dysfunction: does it matter? Is it reversible? J Am Coll Cardiol: 1997; 30 325 333 (Pubitemid 27339309)
2. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature: 2001; 414 813 820 (Pubitemid 34000785)
3. Swerdlow A J, Jones M E. Mortality during 25 years of follow-up of a cohort with diabetes. Int J Epidemiol: 1996; 25 1250 1261 (Pubitemid 27013533)
4. Jarvisalo M J, Raitakari M, Toikka J O et al. Endothelial dysfunction and increased arterial intima-media thickness in children with type 1 diabetes. Circulation: 2004; 109 1750 1755 (Pubitemid 38500678)
5. Dogra G, Rich L, Stanton K et al. Endothelium-dependent and independent vasodilation studies at normoglycaemia in type I diabetes mellitus with and without microalbuminuria. Diabetologia: 2001; 44 593 601 (Pubitemid 32411275)
6. Henry R M, Ferreira I, Kostense P J et al. Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not: the Hoorn Study. Atherosclerosis: 2004; 174 49 56 (Pubitemid 38595439)
7. James P E, Lang D T, Tufnell-Barret T et al. Vasorelaxation by red cells and impairment in diabetes. Cir Res: 2004; 94 976 983
8. Sydo K, Mondon C E, Cooke J P. Insulin resistance: potential role of the endogenous nitric oxide synthase inhibitor ADMA. Vasc Med: 2005; 10 S35 S43 (Pubitemid 43137266)
9. Corretti M C, Anderson T J, Benjamin E J et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilatation of the brachial artery: a report of the International Brachial artery Reactivity Task Force. J Am Coll Cardiol: 2002; 16 257 265 (Pubitemid 34084631)
10. Mabley J G, Soriano F G. Role of nitrosative stress and poly (ADPribose) polymerase activation in diabetic vascular dysfunction. Current Vascular Pharmacol: 2005; 3 247 252 (Pubitemid 40933047)
11. King G L, Loeken M R. Hyperglycemia-induced oxidative stress in diabetic complications. Histochemistry and Cell Biology: 2004; 122 333 338 (Pubitemid 39506591)
12. Zou M H, Shi C, Cohen R A. High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H (2) receptor mediated apoptosis and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes: 2002; 51 198 203 (Pubitemid 34517998)
13. Rajagopalan S, Brook R, Mehta R H et al. Effect of Losartan in aging-related endothelial impairment. Am J Cardiol: 2002; 89 562 566 (Pubitemid 34178568)
14. Zhang X, Zhao S P, Li X P et al. Endothelium-dependent and independent functions are impaired in patients with coronary heart disease. Atherosclerosis: 2000; 149 19 24 (Pubitemid 30125967)
15. Macey M, McCarthy D, Azam U et al. Ethylene diamine tetraacetic acid plus citrate-theophylline-adenosine-dipyridamole (EDTA-CTAD): a novel anticoagulant for the flow cytometric assessment of platelet and neutrophil activation ex vivo in whole blood. Cytometry B Clin Cytom: 2003; 51 30 40 (Pubitemid 38292622)
16. Goon P, Boos C, Stonelake S et al. Detection and quantification of mature circulating endothelial cells using flow cytometry and immunomagnetic beads: A methodological comparison. Thromb Haemost: 2006; 96 45 52 (Pubitemid 44160870)
17. Woywodt A, Blann A D, Kirsch T et al. Isolation and enumeration of circulating endothelial cells by immunomagnetic isolation: proposal of a definition and a consensus protocol. J Thromb Haemost: 2006; 4 671 677
18. Granger D L, Taintor R R, Boockvar K S et al. Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction. Methods Enzymol: 1996; 268 142 151 (Pubitemid 26286356)
19. Grisham M B, Johnson G G, Lancaster J R Jr. Quantitation of nitrate and nitrite in extracellular fluids. Methods Enzymol: 1996; 268 237 246 (Pubitemid 26286366)
20. Felmeden D C, Blann A D, Spencer C G et al. A comparison of flow-mediated dilatation and von Willebrand factor as markers of endothelial cell function in health and in hypertension: relationship to cardiovascular risk and effects of treatment: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial. Blood Coagul Fibrinolysis: 2003; 14 425 431 (Pubitemid 36951858)
21. Hashimoto M, Kozaki K, Eto M et al. Association of coronary risk factors and endothelium-dependent flow-mediated dilatation of the brachial artery. Hypertens Res: 2000; 23 233 238 (Pubitemid 30326252)
22. Makin A J, Chung NA Y, Silverman S H et al. Assessment of endothelial damage in atherosclerotic vascular disease by quantification of circulating endothelial cells. Eur Heart J: 2004; 25 371 376 (Pubitemid 38391518)
23. Khan S S, Solomon M A, McCoy J P Jr. Detection of circulating endothelial cells and endothelial progenitor cells by flow cytometry. Cytometry. Part B. Clinical Cytometry: 2005; 64 1 8 (Pubitemid 40960406)
24. Nakatani K, Takeshita S, Tsujimoto H et al. Circulating endothelial cells in Kawasaki disease. Clinical and Experimental Immunology: 2003; 131 536 540 (Pubitemid 36324146)
25. Woywodt A, Streiber F, de Groot K et al. Circulating endothelial cells as markers for ANCA associated small-vessel vasculitis. Lancet: 2003; 361 206 210 (Pubitemid 36126220)
26. McClung J A, Naseer N, Saleem M et al. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA (1)c. Diabetologia: 2005; 48 345 350 (Pubitemid 40543308)
27. Mutin M, Canavy I, Blann A et al. Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells. Blood: 1999; 93 2951 2958 (Pubitemid 29200786)
28. Zou N H. Shi, Cohen R A. High glucose via peroxynitrite causes tyrosine nitration and inactivation of prostacyclin synthase that is associated with thromboxane/prostaglandin H (2) receptor mediated apoptosos and adhesion molecule expression in cultured human aortic endothelial cells. Diabetes: 2002; 51 198 203 (Pubitemid 34517998)
29. Du X, Stocklauser-Farber K, Rosen P. Generation of reactive oxygen intermediates, activation of NF-Kappa B and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radical Biology & Medicine: 1999; 27 752 763 (Pubitemid 29454578)
30. Nakao-Hayashi J, Ito H, Kawashima S. An oxidative mechanism is involved in high glucose-induced serum protein modification causing inhibition of endothelial cell proliferation. Atherosclerosis: 1992; 97 89 95
31. Curcio F, Ceriello A. Decreased cultured endothelial cell proliferation in high glucose medium is reversed by antioxidant: new insights on the pathphysiological mechanisms of diabetic vascular complications. In Vitro Cellular& Developmental Biology: 1992; 28 787 790 (Pubitemid 23054054)
32. Lorenzi M, Nordebrg J A, Toledo S. High glucose prolongs cell cycle traversal of cultured human endothelial cells. Diabetes: 1987; 36 1261 1267 (Pubitemid 17163984)
33. McClung J A, Saleem M, Rossi G P et al. Circulating endothelial cells are elevated in patients with type 2 diabetes mellitus independently of HbA (1)c. Diabetologia: 2005; 48 345 350 (Pubitemid 40543308)
34. Tank C, Chow W S, Ai V H et al. Advanced end glycation products and endothelial dysfunction in type 2 diabetes. Diabetes care: 2002; 25 1055 1059 (Pubitemid 41110493)
35. Henry R M. Ferreira, Kostensa P J et al. Type 2 diabetes is associated with impaired endothelial dependent flow mediated dilatation but impaired glucose metabolism is not. The Hoom study. Atherosclerosis: 2004; 174 49 56 (Pubitemid 38595439)
36. Windeban K A, Feldman E. diabetes and the nervous system. In: Neurology and General Medicine. Aminoff M. (ed.). Philadelphia, PA Churchill Livingstone: 2001; 341 346
37. Singh R, Barden A. Motit et al. Advanced glycation end-product; a review. Diabetologia: 2001; 44 129 146
38. Shahid S M, Mahboob T. Correlation between glycosylated hemoglobin (HbA1c) and serum Nitric oxide (NO). Aust J Basic Appl Sci: 2009; 3 1323 1327
39. Holmen C, Elsheikh E, Stenvinkel P. Circulating inflammatory endothelial cells contribute to endothelial progenitor cell dysfunction in patients with vasculitis and kidney involvement. J Am Soc Nephrol: 2005; 16 3110 3120 (Pubitemid 44743509)